BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30883611)

  • 1. GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma.
    Liu X; Zhang Q; Fan C; Tian J; Liu X; Li G
    PLoS One; 2019; 14(3):e0214073. PubMed ID: 30883611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
    Xu H; Gong J; Liu H
    PLoS One; 2017; 12(12):e0189675. PubMed ID: 29244840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machine learning-based integrative analysis of methylome and transcriptome identifies novel prognostic DNA methylation signature in uveal melanoma.
    Hou P; Bao S; Fan D; Yan C; Su J; Qu J; Zhou M
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33367533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival.
    Zhu X; Luo X; Feng G; Huang H; He Y; Ma W; Zhang C; Zeng M; Liu H
    PLoS One; 2019; 14(2):e0207341. PubMed ID: 30716092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D; Luo L; Liang C
    PLoS One; 2018; 13(5):e0197402. PubMed ID: 29746588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
    Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
    van der Velden PA; Metzelaar-Blok JA; Bergman W; Monique H; Hurks H; Frants RR; Gruis NA; Jager MJ
    Cancer Res; 2001 Jul; 61(13):5303-6. PubMed ID: 11431374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMX1B mRNA expression and its gene body CpG methylation are valuable prognostic biomarkers for laryngeal squamous cell carcinoma.
    Fan L; Zhang A; Deng P
    Biomed Pharmacother; 2019 Sep; 117():109174. PubMed ID: 31387183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repression of genes involved in melanocyte differentiation in uveal melanoma.
    Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
    Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
    Tang J; Wan Q; Lu J
    BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of growth differentiation factor 11 in colorectal cancer.
    Yokoe T; Ohmachi T; Inoue H; Mimori K; Tanaka F; Kusunoki M; Mori M
    Int J Oncol; 2007 Nov; 31(5):1097-101. PubMed ID: 17912435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes.
    Kucherlapati M
    BMC Cancer; 2018 Aug; 18(1):818. PubMed ID: 30107825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of genome-wide DNA methylation patterns in noncoding miRNAs and lncRNAs in uveal melanomas.
    Zheng Z; Xu D; Shi K; Chen M; Lu F
    Aging (Albany NY); 2019 Aug; 11(16):6153-6174. PubMed ID: 31433788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JARID1B protein expression and prognostic implications in uveal melanoma.
    Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation status of multiple genes in uveal melanoma.
    Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of oxidative phosphorylation-related prognostic risk score model in uveal melanoma.
    Zhan Z; Lin K; Wang T
    BMC Ophthalmol; 2024 May; 24(1):204. PubMed ID: 38698303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.